Literature DB >> 19223087

Association between atherosclerosis and newly classified chronic kidney disease stage for Japanese patients with type 2 diabetes.

Risako Yamamoto1, Akio Kanazawa, Tomoaki Shimizu, Takahisa Hirose, Yasushi Tanaka, Ryuzo Kawamori, Hirotaka Watada.   

Abstract

Using a new estimated glomerular filtration rate (eGFR) equation, we undertook a retrospective chart review to investigate the clinical significance of chronic kidney disease (CKD) stage for atherosclerosis in 653 Japanese patients with type 2 diabetes that were followed from January 2004 to December 2006 at Juntendo University Hospital. Diabetic patients with CKD stage 2 or 3 detected in 2004 or before had more history of cardiovascular disease (CVD) compared with those patients without CKD [ischemic heart disease (IHD): 25% vs. 9.3%, P<0.01 and stroke: 17.6% vs. 10.5%, P<0.05]. In Addition, the incidence of CVD through the observation period tended to increase with progression of CKD stage (0.9% in stage 0, 3.2% in stage 1 or 2, and 3.4% in stage > or =3, P=0.056), and patients with eGFR<75 had a higher incidence of IHD (2.5% vs. 0.3%) and IHD or Stroke (3.3% vs. 0.7%) compared with those who had eGFR > or =75. Patients with urinary albumin excretion rate (UACR) > or =20mg/g Cr also had a higher incidence of IHD or stroke compared to patients with UACR<20 (3.5% vs. 0.6%). In conclusion, diabetic patients with eGFR<75 and/or UACR > or =20 might be a high-risk population for CVD.

Entities:  

Mesh:

Year:  2009        PMID: 19223087     DOI: 10.1016/j.diabres.2009.01.009

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

1.  Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia.

Authors:  Kentaro Tanaka; Shigeko Hara; Akifumi Kushiyama; Yoshifumi Ubara; Yoko Yoshida; Sonoo Mizuiri; Atsushi Aikawa; Shouji Kawatzu
Journal:  Clin Exp Nephrol       Date:  2011-02-18       Impact factor: 2.801

2.  GCK, GCKR polymorphisms and risk of chronic kidney disease in Japanese individuals: data from the J-MICC Study.

Authors:  Asahi Hishida; Naoyuki Takashima; Tanvir Chowdhury Turin; Sayo Kawai; Kenji Wakai; Nobuyuki Hamajima; Satoyo Hosono; Yuichiro Nishida; Sadao Suzuki; Noriko Nakahata; Haruo Mikami; Keizo Ohnaka; Daisuke Matsui; Sakurako Katsuura-Kamano; Michiaki Kubo; Hideo Tanaka; Yoshikuni Kita
Journal:  J Nephrol       Date:  2013-12-17       Impact factor: 3.902

Review 3.  Astaxanthin: a potential therapeutic agent in cardiovascular disease.

Authors:  Robert G Fassett; Jeff S Coombes
Journal:  Mar Drugs       Date:  2011-03-21       Impact factor: 5.118

4.  Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes.

Authors:  Arnaud D Kaze; Bernard G Jaar; Gregg C Fonarow; Justin B Echouffo-Tcheugui
Journal:  BMC Med       Date:  2022-03-29       Impact factor: 8.775

5.  Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure.

Authors:  Ai-Ching Boon; Alfred K Lam; Vinod Gopalan; Iris F Benzie; David Briskey; Jeff S Coombes; Robert G Fassett; Andrew C Bulmer
Journal:  Sci Rep       Date:  2015-10-26       Impact factor: 4.379

6.  Polymorphisms in genes encoding antioxidant enzymes (SOD2, CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.

Authors:  Asahi Hishida; Rieko Okada; Mariko Naito; Emi Morita; Kenji Wakai; Nobuyuki Hamajima; Satoyo Hosono; Hinako Nanri; Tanvir Chowdhury Turin; Sadao Suzuki; Kazuyo Kuwabara; Haruo Mikami; Sanjeev Budhathoki; Isao Watanabe; Kokichi Arisawa; Michiaki Kubo; Hideo Tanaka
Journal:  J Clin Biochem Nutr       Date:  2013-06-01       Impact factor: 3.114

7.  Polymorphisms in PPAR Genes (PPARD, PPARG, and PPARGC1A) and the Risk of Chronic Kidney Disease in Japanese: Cross-Sectional Data from the J-MICC Study.

Authors:  Asahi Hishida; Kenji Wakai; Mariko Naito; Takashi Tamura; Sayo Kawai; Nobuyuki Hamajima; Isao Oze; Takeshi Imaizumi; Tanvir Chowdhury Turin; Sadao Suzuki; Motahare Kheradmand; Haruo Mikami; Keizo Ohnaka; Yoshiyuki Watanabe; Kokichi Arisawa; Michiaki Kubo; Hideo Tanaka
Journal:  PPAR Res       Date:  2013-11-07       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.